Table 1.
Study participants’ demographic information
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Normal control | Mean age ± SD | |||||||||
| # 5 | 37.4 ± 11 | |||||||||
| Luminal A | Age (Y) | Age at onset (Y) | R/L | Type | Grade | Stage | ER | PR | Her2 | Ki67 |
| BC patients | ||||||||||
|
| ||||||||||
| P1 | 47 | 46 | R | D | 2 | 1A | 70 | 70 | N | 25 |
| P2 | 47 | 46 | L | D | 2 | 2A | 100 | 100 | N | 25 |
| P3 | 45 | 44 | R | L | 2 | 2A | 80 | 80 | N | 12.5 |
| P4 | 26 | 26 | R | D | 2 | 3A | 100 | 100 | N | 13.5 |
| P5 | 76 | 75 | L | D | 2 | 2B | 100 | 100 | N | 11.5 |
| P6 | 42 | 41 | L | D | 1 | 2A | 100 | 90 | N | 7.5 |
| P7 | 42 | 41 | R | D | 1 | 2A | 90 | 90 | N | 5 |
| P8 | 44 | 43 | R | D | 1 | 2A | 100 | 90 | N | 13.5 |
| P9 | 45 | 44 | R | D | 1 | 1A | 95 | 70 | N | 2 |
| P10 | 46 | 45 | R | D | 2 | 1A | 100 | 100 | N | 4.5 |
| Mean ± SD | 46 ± 11.58 | 45.1 ± 11.41 | 93.5 ± 10.01 | 89 ± 11.36 | 12 ± 7.54 | |||||
|
| ||||||||||
BC; Breast cancer, P1-P10; Patient number, R/L; Right/left, ER; Oestrogen receptor, PR; Progesterone receptor, and SD; Standard deviation.